Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Indaptus Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "Indaptus Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
08/10/2023 8-K Other Events  Interactive Data
05/25/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "Indaptus Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update"
03/27/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/24/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/17/2023 10-K Annual Report for the period ended December 31, 2022
03/17/2023 8-K Quarterly results
Docs: "Indaptus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update"
02/14/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/03/2023 EFFECT Form EFFECT - Notice of Effectiveness:
12/30/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
09/30/2022 8-K Quarterly results
09/12/2022 EFFECT Form EFFECT - Notice of Effectiveness:
09/09/2022 RW Form RW - Registration Withdrawal Request:
09/01/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
Docs: "Unaudited Condensed Consolidated Balance Sheets June 30, 2022 December 31, 2021 Assets Current assets: Cash and cash equivalents $ 14,258,812 $ 39,132,165 Marketable securities 18,753,081 - Assets held for sale - 148,400 Prepaid expenses and other current assets 260,884 1,106,653 Total current assets 33,272,777 40,387,218 Non-current assets: Property and equipment, net 2,732 3,800 Right-of-use asset 124,853 169,088 Other assets 659,049 16,477 Total non-current assets 786,634 189,365 Total assets $ 34,059,411 $ 40,576,583 Liabilities and stockholders’ equity Current liabilities: Accounts payable and other current liabilities $ 3,526,034 $ 4,507,676 Operating lease liability, current portion 97,905 96,465 Total current liabilities 3,623,939 4,604,141 Non-current liabilities: Operating lease ..."
08/04/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/04/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
07/21/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "AMENDMENT NO. 1"
07/07/2022 SC 13G/A Anderson Glen R. reports a 13.2% stake in Indaptus Therapeutics, Inc.
06/01/2022 8-K Quarterly results
06/01/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
05/27/2022 AW Form AW - Amendment Withdrawal Request:
05/19/2022 8-K Quarterly results
05/12/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/12/2022 8-K Quarterly results
03/25/2022 AW Form AW - Amendment Withdrawal Request:
03/24/2022 EFFECT Form EFFECT - Notice of Effectiveness:
03/22/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/21/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy